reducing over (under) treatment and associated side effects
absorbent paper
As Siglec-15 is mutually exclusive to PD-L1
VHHPPSYVAHLASDFGVRVFQQVAQASKDRNVVFSPYGVASVLAMLQLTTGGETQQQIQAAMGFKIDDKGMAPALRHLYKELMGPWNKDEISTTDAIFVQRDLKLVQGFMPHFFRLFRSTVKQVDFSEVERARFIINDWVKTHTKGMISNLLGKGAVDQLTRLVLVNALYFNGQWKTPFPDSSTHRRLFHKSDGSTVSVPMMAQTNKFNYTEFTTPDGHYYDILELPYHGDTLSMFIAAPYEKEVPLSALTNILSAQLISHWKGNMTRLPRLLVLPKFSLETEVDLRKPLENLGMTDMFRQFQADFTSLSDQEPLHVAQALQKVKIEVNESGTVASSSTAVIVSARMAPEEIIMDRPFLFVVRHNPTGTVLFMGQVMEPGGGGSHHHHHHHHHH
Anti-mCD20-mIgG2a is provided in an Invivo grade
Human Laminin gamma 1, His Tag Isotype control reducing over (under) treatment andProduct Specification Species Human Synonyms aminin subunit gamma 1, Laminin B2 chain, Laminin 1 subunit gamma, Laminin 10 subunit gamma, Laminin 11 subunit gamma, Laminin 2 subunit gamma, LAMC1 Accession P11047 Amino Acid Sequence Protein sequence(P11047, Gln34 Leu484, with C 10*His)